Literature DB >> 1626607

Use of color Doppler imaging in the distinction between thyroid and parathyroid lesions.

G A Gooding1, O H Clark.   

Abstract

To determine whether the use of color Doppler imaging in conjunction with standard high-resolution 10-MHz ultrasound could increase the screening sensitivity in distinguishing between thyroid and parathyroid lesions in the detection of parathyroid disease, we studied 32 patients with hyperparathyroidism with both modalities who were subsequently treated surgically. Among these 32 patients, parathyroid lesions were predominantly avascular (n = 21, average size 0.9 x 0.6 cm) but with increased size demonstrated some vascularity (n = 9, average size 2.1 x 1 cm, 32%). Of these 32 patients, 46.6% had thyroid lesions as well. Thyroid lesions were avascular when small (n = 26 lesions, average size 0.5 x 0.5 cm) but tended to demonstrate vascularity (n = 14, 35%) at about 1 cm in size or greater. Although the addition of color Doppler imaging enabled the differentiation of vessel from soft-tissue abnormalities and some distinction between parathyroid and thyroid lesions, it had no effect on overall sensitivity (65%) in the detection of parathyroid disease.

Entities:  

Mesh:

Year:  1992        PMID: 1626607     DOI: 10.1016/s0002-9610(05)80645-2

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  2 in total

1.  Clinical value and limitations of [11C]-methionine PET for detection and localization of suspected parathyroid adenomas.

Authors:  Ken Herrmann; Toshiki Takei; Kakuko Kanegae; Tohru Shiga; Andreas K Buck; Jennifer Altomonte; Markus Schwaiger; Tibor Schuster; Kenichi Nishijima; Yuji Kuge; Nagara Tamaki
Journal:  Mol Imaging Biol       Date:  2009-04-02       Impact factor: 3.488

2.  The value of clinical-ultrasonographic feature model to predict the severity of secondary hyperparathyroidism.

Authors:  Xiaoer Zhang; Wenxin Xu; Tongyi Huang; Jingzhi Huang; Chunyang Zhang; Yutong Zhang; Xiaoyan Xie; Ming Xu
Journal:  Ren Fail       Date:  2022-12       Impact factor: 2.606

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.